Abstract
For several decades, androgen suppression has been the principal modality for treatment of advanced prostate cancer. Although the androgen deprivation is initially effective, most patients experience a relapse within several years due to the proliferation of so-called androgen-independent tumor cells. Bruchovsky et al. suggested in animal models that intermittent androgen suppression (IAS) can prolong the time to relapse when compared with continuous androgen suppression (CAS). Therefore, IAS has been expected to enhance clinical efficacy in conjunction with reduction in adverse effects and improvement in quality of life of patients during off-treatment periods. This paper presents a mathematical model that describes the growth of a prostate tumor under IAS therapy based on monitoring of the serum prostate-specific antigen (PSA). By treating the cancer tumor as a mixed assembly of androgen-dependent and androgen-independent cells, we investigate the difference between CAS and IAS with respect to factors affecting an androgen-independent relapse. Numerical and bifurcation analyses show how the tumor growth and the relapse time are influenced by the net growth rate of the androgen-independent cells, a protocol of the IAS therapy, and the mutation rate from androgen-dependent cells to androgen-independent ones.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AD::
-
androgen-dependent;
- ADT::
-
androgen deprivation therapy;
- AI::
-
androgen-independent;
- CAS::
-
continuous androgen suppression;
- IAS::
-
intermittent androgen suppression;
- LHRH::
-
luteinizing hormone releasing hormone;
- MAB::
-
maximal androgen blockade;
- PSA::
-
prostate-specific antigen.
References
Abarbanel, H.D.I.: Analysis of Observed Chaotic Data. Springer, New York (1996)
Akakura, K., Bruchovsky, N., Goldenberg, S.L., Rennie, P.S., Buckley, A.R., Sullivan, L.D.: Effects of intermittent androgen suppression on androgen-dependent tumors: Apoptosis and serum prostate-specific antigen. Cancer 71(9), 2782–2790 (1993)
Berges, R.R., Vukanovic, J., Epstein, J.I., CarMichel, M., Cisek, L., Johnson, D.E., Veltri, R.W., Walsh, P.C., Isaacs, J.T.: Implication of cell kinetic changes during the progression of human prostatic cancer. Clin. Cancer Res. 1, 473–480 (1995)
Bhandari, M.S., Crook, J., Hussain, M.: Should intermittent androgen deprivation be used in routine clinical practice? J. Clin. Oncol. 23(32), 8212–8218 (2005)
Bladou, F., Vessella, R.L., Buhler, K.R., Ellis, W.J., True, L.D., Lange, P.H.: Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration. Int. J. Cancer 67, 785–790 (1996)
Bruchovsky, N., Rennie, P.S., Coldman, A.J., Goldenberg, S.L., To, M., Lawson, D.: Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res. 50(8), 2275–2282 (1990)
Bruchovsky, N., Snoek, R., Rennie, P.S., Akakura, K., Goldenberg, S.L., Gleave, M.: Control of tumor progression by maintenance of apoptosis. Prostate Suppl. 6, 13–21 (1996)
Bruchovsky, N., Klotz, L.H., Sadar, M., Crook, J.M., Hoffart, D., Godwin, L., Warkentin, M., Gleave, M.E., Goldenberg, S.L.: Intermittent androgen suppression for prostate cancer: Canadian prospective trial and related observations. Mol. Urol. 4(3), 191–199 (2000)
Bruchovsky, N., Goldenberg, S.L., Mawji, N.R., Sadar, M.D.: Evolving aspects of intermittent androgen blockade for prostate cancer: diagnosis and treatment of early tumor progression and maintenance of remission. In: Andrology in the 21st Century. Proceedings of the VIIth International Congress of Andrology, pp. 609–623 (2001)
Bruchovsky, N., Klotz, L., Crook, J., Malone, S., Ludgate, C., Morris, W.J., Gleave, M.E., Goldenberg, S.L.: Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: Clinical parameters. Cancer 107(2), 389–395 (2006)
Bruchovsky, N., Klotz, L., Crook, J., Larry, S., Goldenberg, S.L.: Locally advanced prostate cancer—Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy. Cancer 109(5), 858–867 (2007)
Byrne, H.M., Alarcon, T., Owen, M.R., Webb, S.D., Maini, P.K.: Modelling aspects of cancer dynamics: A review. Phil. Trans. R. Soc. A 364, 1563–1578 (2006)
Chuu, C., Hiipakka, R.A., Fukuchi, J., Kokontis, J.M., Liao, S.: Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice. Cancer Res. 65(6), 2082–2084 (2005)
Dehm, S.M., Tindall, D.J.: Regulation of androgen receptor signaling in prostate cancer. Expert Rev. Anticancer Ther. 5(1), 63–74 (2005)
Edwards, J., Bartlett, J.M.S.: The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor. BJU Int. 95, 1320–1326 (2005)
Feldman, B.J., Feldman, D.: The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1, 34–45 (2001)
Goldenberg, S.L., Bruchovsky, N., Gleave, M.E., Sullivan, L.D., Akakura, K.: Intermittent androgen suppression in the treatment of prostate cancer: A preliminary report. Urology 45, 839–844 (1995)
Guckenheimer, J., Johnson, S.: Planar hybrid systems. In: Hybrid Systems II. Lecture Notes in Computer Science, vol. 999, pp. 202–225. Springer, Berlin (1995)
Huggins, C., Hodges, C.V.: Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1, 293–297 (1941)
Jackson, T.L.: A mathematical model of prostate tumor growth and androgen-independent relapse. Discrete Cont. Dyn. Syst. Ser. B 4(1), 187–201 (2004a)
Jackson, T.L.: A mathematical investigation of the multiple pathways to recurrent prostate cancer: Comparision with experimental data. Neoplasia 6(6), 697–704 (2004b)
Johnson, S.D.: Simple hybrid systems. Int. J. Bifurcat. Chaos 4(6), 1655–1665 (1994)
Kantz, H., Schreiber, T.: Nonlinear Time Series Analysis. Cambridge University Press, Cambridge (1997)
Kokontis, J., Takakura, K., Hay, N., Liao, S.: Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res. 54, 1566–1573 (1994)
Kokontis, J., Hay, N., Liao, S.: Progression of LNCaP prostate tumor cells during androgen deprivation: Hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol. Endocrinol. 12(7), 941–953 (1998)
Kokontis, J., Hsu, S., Chuu, C., Dang, M., Fukuchi, J., Hiipakka, R.A., Liao, S.: Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity. Prostate 65(4), 287–298 (2005)
Kousaka, T., Ueta, T., Kawakami, H.: Bifurcation of switched nonlinear dynamical systems. IEEE Trans. Circ. Syst. II 46(7), 878–885 (1999)
McLeod, D.G.: Hormonal therapy: Historical perspective to future directions. Urology 61, 3–7 (2003)
Nelson, W.G., De Marzo, A.M., Isaacs, W.B.: Mechanisms of disease: Prostate cancer. N. Engl. J. Med. 349, 366–381 (2003)
Ott, E., Sauer, T., Yorke, J.A. (eds.): Coping with Chaos. Wiley, New York (1994)
Sauer, T., Yorke, J.A., Casdagli, M.: Embedology. J. Stat. Phys. 65(3/4), 579–616 (1991)
Savkin, A.V., Evans, R.J.: Hybrid Dynamical Systems: Controller and Sensor Switching Problems. Springer, Berlin (2001)
Scher, H.I., Buchanan, G., Gerald, W., Butler, L.M., Tilley, W.D.: Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocr.-Relat. Cancer 11, 459–476 (2004)
Shimada, T., Aihara, K.: A nonlinear model with competition between tumor cells and its application to intermittent androgen suppression therapy of prostate cancer. Tech. rep., Department of Mathematical Informatics, Graduate School of Information Science and Technology, University of Tokyo, METR 2007-10, Feb. (2007)
Swanson, K.R., True, L.D., Lin, D.W., Buhler, K.R., Vessella, R., Murray, J.D.: A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth: An explanation for a medical anomaly. Am. J. Pathol. 158(6), 2195–2199 (2001)
van der Schaft, A.J., Schumacher, J.M.: An Introduction to Hybrid Dynamical Systems. Lecture Notes in Control and Information Sciences, vol. 251. Springer, Berlin (2000)
Weigend, A.S., Gershenfeld, N.A. (eds.): Time Series Prediction: Forecasting the Future and Understanding the Past. Addison-Wesley, Reading (1994)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ideta, A.M., Tanaka, G., Takeuchi, T. et al. A Mathematical Model of Intermittent Androgen Suppression for Prostate Cancer. J Nonlinear Sci 18, 593 (2008). https://doi.org/10.1007/s00332-008-9031-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00332-008-9031-0
Keywords
- Prostate cancer
- Intermittent androgen suppression
- Mathematical modeling
- Hybrid systems
- Hysteresis
- Bifurcations